SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,319,000 | +1504.8% | 550,000 | +3566.7% | 0.04% | +800.0% |
Q2 2023 | $705,300 | -86.9% | 15,000 | -88.3% | 0.01% | -79.2% |
Q1 2023 | $5,398,406 | -51.2% | 128,656 | -55.6% | 0.02% | -78.8% |
Q4 2022 | $11,060,600 | -4.3% | 290,000 | -1.7% | 0.11% | +10.8% |
Q3 2022 | $11,552,000 | +21.2% | 295,000 | 0.0% | 0.10% | +41.7% |
Q2 2022 | $9,529,000 | +539.5% | 295,000 | +555.6% | 0.07% | +260.0% |
Q1 2022 | $1,490,000 | -29.9% | 45,000 | -10.0% | 0.02% | -9.1% |
Q4 2021 | $2,127,000 | +92.0% | 50,000 | +100.0% | 0.02% | +46.7% |
Q3 2021 | $1,108,000 | -82.2% | 25,000 | -83.3% | 0.02% | -86.2% |
Q2 2020 | $6,237,000 | +141.3% | 150,000 | +66.7% | 0.11% | +67.7% |
Q1 2020 | $2,585,000 | +84.2% | 90,000 | +800.0% | 0.06% | +66.7% |
Q3 2019 | $1,403,000 | -23.4% | 10,000 | 0.0% | 0.04% | -7.1% |
Q2 2019 | $1,831,000 | -42.4% | 10,000 | -50.0% | 0.04% | +2.4% |
Q1 2019 | $3,181,000 | +66.0% | 20,000 | 0.0% | 0.04% | +57.7% |
Q4 2018 | $1,916,000 | +207.5% | 20,000 | +100.0% | 0.03% | +73.3% |
Q3 2017 | $623,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |